{"id":2051,"date":"2025-09-25T16:44:58","date_gmt":"2025-09-25T23:44:58","guid":{"rendered":"https:\/\/phcventures.ca\/?p=2051"},"modified":"2025-10-17T15:16:18","modified_gmt":"2025-10-17T22:16:18","slug":"ai-virtual-biomarker-cancer-research","status":"publish","type":"post","link":"https:\/\/phcventures.ca\/fr\/ai-virtual-biomarker-cancer-research\/","title":{"rendered":"Le partenariat de Vancouver utilise la coloration virtuelle des biomarqueurs pilot\u00e9e par l'IA pour acc\u00e9l\u00e9rer la recherche sur le cancer et la pathologie num\u00e9rique"},"content":{"rendered":"<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"500\" src=\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg\" alt=\"AI Virtual Biomarker Staining Speeds Cancer Research\" class=\"wp-image-2052\" srcset=\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg 800w, https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research-300x188.jpg 300w, https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research-768x480.jpg 768w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" \/><\/figure>\n\n\n\n<h4 class=\"wp-block-heading\">Une nouvelle technologie pourrait r\u00e9duire le temps d'analyse des tissus de plusieurs semaines \u00e0 quelques jours, ce qui permettrait de faire progresser les flux de recherche et d'am\u00e9liorer les futurs parcours de soins des patients.&nbsp;<\/h4>\n\n\n\n<p>Vancouver, BC - 25 septembre 2025 - Un nouveau partenariat entre Providence Health Care Ventures (PHCV) et la soci\u00e9t\u00e9 ViewsML, bas\u00e9e \u00e0 Vancouver, utilisera l'intelligence artificielle pour acc\u00e9l\u00e9rer les flux de travail de la recherche et faire progresser les capacit\u00e9s de pathologie num\u00e9rique pour l'analyse des \u00e9chantillons de tissus.&nbsp;<\/p>\n\n\n\n<p>Cette collaboration associe la vaste biblioth\u00e8que d'\u00e9chantillons de tissus de Providence Health Care (PHC) et les ressources de pathologie num\u00e9rique accessibles via son Integrated Health Informatics Datalab (IHID) s\u00e9curis\u00e9 \u00e0 la plateforme de coloration virtuelle pilot\u00e9e par l'IA de ViewsML, qui peut identifier des marqueurs de maladie sans avoir recours \u00e0 des anticorps physiques ni au test traditionnel d'immunohistochimie (IHC) en laboratoire humide. C'est un peu comme si l'on disposait d'un assistant de pathologie num\u00e9rique capable de rep\u00e9rer ce que les chercheurs ont besoin de voir en quelques minutes plut\u00f4t qu'en quelques semaines.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Des flux de recherche plus rapides&nbsp;<\/h2>\n\n\n\n<p>Aujourd'hui, lorsque les chercheurs analysent des \u00e9chantillons de tissus, il faut parfois des semaines pour obtenir des r\u00e9sultats, car les \u00e9chantillons passent par de multiples processus de laboratoire. La technologie de ViewsML permet d'analyser une seule lame de tissu et de recr\u00e9er virtuellement ce qui, normalement, consommerait des tissus pr\u00e9cieux et rares, n\u00e9cessiterait des tests d'anticorps co\u00fbteux et des proc\u00e9dures de coloration sp\u00e9cialis\u00e9es \u00e0 des fins de recherche.<\/p>\n\n\n\n<p>\u201cCette collaboration change la donne car elle permet de transformer plus rapidement la recherche en impact sur les patients, en acc\u00e9l\u00e9rant le d\u00e9veloppement de nouvelles th\u00e9rapies, en am\u00e9liorant la pr\u00e9cision de la recherche et en r\u00e9duisant les retards dans les flux de travail de la recherche translationnelle\u201d, a d\u00e9clar\u00e9 Brian Simmers, pr\u00e9sident de Providence Health Care Ventures.<\/p>\n\n\n\n<p><strong>Le partenariat propose des candidatures imm\u00e9diates :<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Recherche sur le cancer<\/strong>: Identification plus rapide des caract\u00e9ristiques des tumeurs pour les \u00e9tudes de recherche<\/li>\n\n\n\n<li><strong>Essais cliniques<\/strong>: Adaptation plus rapide des patients aux th\u00e9rapies exp\u00e9rimentales gr\u00e2ce \u00e0 une meilleure analyse des biomarqueurs<\/li>\n\n\n\n<li><strong>Flux de travail de la recherche<\/strong>: Meilleure utilisation des pr\u00e9cieux \u00e9chantillons de tissus pour plusieurs \u00e9tudes simultan\u00e9es<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Soutenir le p\u00f4le d'innovation de Vancouver<\/h2>\n\n\n\n<p>Cette collaboration positionnera le nouveau centre de soutien et de recherche clinique (CSRC) de l'h\u00f4pital St. Paul comme un leader mondial de l'innovation en mati\u00e8re de sant\u00e9, en combinant les atouts de la Colombie-Britannique en mati\u00e8re de donn\u00e9es cliniques et de technologie de l'IA.<\/p>\n\n\n\n<p>\u201cLa pathologie entre rapidement dans l'\u00e8re num\u00e9rique, et des technologies comme ViewsML ont le potentiel de transformer la fa\u00e7on dont nous extrayons des informations des \u00e9chantillons de tissus \u00e0 des fins de recherche. En permettant la d\u00e9couverte de biomarqueurs plus pr\u00e9cis et en soutenant la recherche \u00e0 grande \u00e9chelle, ce type d'innovation pourrait contribuer \u00e0 acc\u00e9l\u00e9rer le d\u00e9veloppement de nouveaux diagnostics et traitements, am\u00e9liorant ainsi les soins futurs aux patients\u201d, a d\u00e9clar\u00e9 le Dr Lik Hang Lee, chef de division, pathologie anatomique, PHC.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Comment \u00e7a marche<\/h2>\n\n\n\n<p>La plateforme d'IA de ViewsML agit comme un laboratoire virtuel pour les applications de recherche, en utilisant l'apprentissage profond pour identifier les marqueurs de maladie qui n\u00e9cessiteraient g\u00e9n\u00e9ralement plusieurs tests co\u00fbteux. \u00c0 partir d'une seule lame de tissu, la technologie peut :<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Identifier des prot\u00e9ines sp\u00e9cifiques et des caract\u00e9ristiques cellulaires pour l'analyse de la recherche<\/li>\n\n\n\n<li>Pr\u00e9dire les r\u00e9actions potentielles des patients au traitement dans le cadre d'\u00e9tudes de recherche<\/li>\n\n\n\n<li>G\u00e9n\u00e9rer des informations pour plusieurs \u00e9tudes simultan\u00e9ment<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"266\" src=\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/AI-Virtual-Biomarker.png\" alt=\"Side-by-side comparison of tissue slide images: H&amp;E stain, physical immunohistochemistry (IHC), and AI-generated virtual IHC. The virtual IHC closely matches the physical IHC, showing biomarker expression around bile ducts. A Receiver Operating Characteristic (ROC) curve on the right demonstrates high accuracy with an AUC score of 0.95.\" class=\"wp-image-2053\" srcset=\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/AI-Virtual-Biomarker.png 1200w, https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/AI-Virtual-Biomarker-300x67.png 300w, https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/AI-Virtual-Biomarker-768x170.png 768w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Commencer par la recherche sur le cancer, aller plus loin<\/h2>\n\n\n\n<p>Le partenariat a d\u00e9marr\u00e9 avec la recherche en oncologie, en utilisant des diapositives num\u00e9ris\u00e9es soigneusement conserv\u00e9es afin de valider la technologie pour les applications de recherche sur le cancer. Les travaux sont d\u00e9j\u00e0 disponibles pour les soci\u00e9t\u00e9s pharmaceutiques et les organismes de recherche qui cherchent \u00e0 acc\u00e9l\u00e9rer les programmes de d\u00e9veloppement de m\u00e9dicaments.<\/p>\n\n\n\n<p>Providence Health Care Ventures et ViewsML pr\u00e9voient d'\u00e9tendre leurs activit\u00e9s \u00e0 la recherche sur les maladies r\u00e9nales, cardiaques et rares, tout en d\u00e9veloppant de nouveaux outils pour les soci\u00e9t\u00e9s pharmaceutiques et de diagnostic.<\/p>\n\n\n\n<p>\u201cTravailler avec Providence nous permet de d\u00e9ployer notre plateforme dans l'un des meilleurs environnements cliniques et de recherche au Canada. En transformant une simple lame H&amp;E en une suite de biomarqueurs virtuellement immunocolor\u00e9s, nous aidons les chercheurs \u00e0 acc\u00e9l\u00e9rer la d\u00e9couverte, \u00e0 conserver des \u00e9chantillons pr\u00e9cieux et \u00e0 g\u00e9n\u00e9rer des connaissances \u00e0 une \u00e9chelle qui n'\u00e9tait pas possible auparavant - tout en s'int\u00e9grant dans les flux de travail existants\u201d, a d\u00e9clar\u00e9 Kenneth To, PDG de ViewsML. \u201cCette collaboration jette \u00e9galement les bases d'une nouvelle fa\u00e7on pour les chercheurs et les biopharmaciens d'acc\u00e9der aux informations sur les tissus. Avec Providence, nous cr\u00e9ons des opportunit\u00e9s pour rendre plus accessibles les \u00e9chantillons virtuellement caract\u00e9ris\u00e9s et les donn\u00e9es sur les biomarqueurs, afin d'acc\u00e9l\u00e9rer la prise de d\u00e9cision et d'ouvrir de nouvelles possibilit\u00e9s en mati\u00e8re de recherche translationnelle et clinique.\u201d<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">\u00c0 propos de Providence Health Care Ventures<\/h4>\n\n\n\n<p>Providence Health Care Ventures est l'organe d'innovation et de commercialisation de Providence Health Care. Providence Health Care Ventures transforme l'expertise clinique, les donn\u00e9es de sant\u00e9 et la recherche translationnelle en partenariats \u00e9volutifs qui acc\u00e9l\u00e8rent l'innovation et apportent des solutions de sant\u00e9 aux patients et aux syst\u00e8mes de sant\u00e9 dans le monde entier.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Contact pour les m\u00e9dias :<\/strong><\/h4>\n\n\n\n<p>Faye Alexander<br>Sp\u00e9cialiste principal de la communication et de l'engagement<br><a href=\"mailto:falexander@providencehealth.bc.ca\">falexander@providencehealth.bc.ca<\/a><\/p>\n\n\n\n<h4 class=\"wp-block-heading\">A propos de ViewsML<\/h4>\n\n\n\n<p>ViewsML transforme la m\u00e9decine de pr\u00e9cision et les diagnostics gr\u00e2ce aux biomarqueurs virtuels. Sa plateforme principale virtualise les anticorps et l'immunomarquage pour pr\u00e9dire l'expression des biomarqueurs au niveau de chaque cellule, \u00e0 la fois spatialement et quantitativement, r\u00e9duisant un processus de plusieurs jours \u00e0 quelques minutes seulement, le tout \u00e0 partir d'une seule image H&amp;E pour s'int\u00e9grer dans les flux de travail actuels. ViewsML permet aux partenaires biopharmaceutiques, universitaires et diagnostiques d'obtenir de nouvelles informations translationnelles, de d\u00e9velopper la recherche sur les biomarqueurs et de faire progresser la m\u00e9decine de pr\u00e9cision plus rapidement et plus efficacement.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Contact m\u00e9dias :<\/strong><\/h4>\n\n\n\n<p>Keith Jalbert<br>Directeur commercial<br><a href=\"mailto:kjalbert@viewsml.com\">kjalbert@viewsml.com<\/a><\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>La nouvelle technologie pourrait r\u00e9duire le temps d'analyse des tissus de quelques semaines \u00e0 quelques jours, ce qui permettrait de faire progresser les flux de recherche et d'am\u00e9liorer les futurs parcours de soins des patients Vancouver, BC - 25 septembre 2025 - Un nouveau partenariat entre Providence Health Care Ventures (PHCV) et ViewsML, bas\u00e9 \u00e0 Vancouver, utilisera l'intelligence artificielle pour acc\u00e9l\u00e9rer les flux de recherche et faire progresser les capacit\u00e9s de pathologie num\u00e9rique pour les \u00e9chantillons de tissus....<\/p>","protected":false},"author":8,"featured_media":2052,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2051","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AI Virtual Biomarker Staining Speeds Cancer Research<\/title>\n<meta name=\"description\" content=\"Providence Health Care Ventures and ViewsML partner to use AI-driven virtual biomarker staining, accelerating cancer research.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/phcventures.ca\/fr\/ai-virtual-biomarker-cancer-research\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AI Virtual Staining Partnership Accelerates Cancer Research\" \/>\n<meta property=\"og:description\" content=\"Providence Health Care Ventures and ViewsML are using AI-driven virtual biomarker staining to speed cancer research and digital pathology\u2014cutting analysis from weeks to days.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/phcventures.ca\/fr\/ai-virtual-biomarker-cancer-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Providence Health Care Ventures\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-25T23:44:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-17T22:16:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Israel Resendiz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Israel Resendiz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/\"},\"author\":{\"name\":\"Israel Resendiz\",\"@id\":\"https:\/\/phcventures.ca\/#\/schema\/person\/c44279ba053e0deec14c02c4f1bdba97\"},\"headline\":\"Vancouver Partnership Uses AI-Driven Virtual Biomarker Staining to Accelerate Cancer Research and Digital Pathology\",\"datePublished\":\"2025-09-25T23:44:58+00:00\",\"dateModified\":\"2025-10-17T22:16:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/\"},\"wordCount\":767,\"publisher\":{\"@id\":\"https:\/\/phcventures.ca\/#organization\"},\"image\":{\"@id\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/\",\"url\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/\",\"name\":\"AI Virtual Biomarker Staining Speeds Cancer Research\",\"isPartOf\":{\"@id\":\"https:\/\/phcventures.ca\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg\",\"datePublished\":\"2025-09-25T23:44:58+00:00\",\"dateModified\":\"2025-10-17T22:16:18+00:00\",\"description\":\"Providence Health Care Ventures and ViewsML partner to use AI-driven virtual biomarker staining, accelerating cancer research.\",\"breadcrumb\":{\"@id\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#primaryimage\",\"url\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg\",\"contentUrl\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg\",\"width\":800,\"height\":500,\"caption\":\"AI Virtual Biomarker Staining Speeds Cancer Research\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/phcventures.ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vancouver Partnership Uses AI-Driven Virtual Biomarker Staining to Accelerate Cancer Research and Digital Pathology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/phcventures.ca\/#website\",\"url\":\"https:\/\/phcventures.ca\/\",\"name\":\"Providence Health Care Ventures\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/phcventures.ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/phcventures.ca\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/phcventures.ca\/#organization\",\"name\":\"Providence Health Care Ventures\",\"url\":\"https:\/\/phcventures.ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/phcventures.ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2024\/01\/PHC-Ventures-NoTagline-RGB-1.svg\",\"contentUrl\":\"https:\/\/phcventures.ca\/wp-content\/uploads\/2024\/01\/PHC-Ventures-NoTagline-RGB-1.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Providence Health Care Ventures\"},\"image\":{\"@id\":\"https:\/\/phcventures.ca\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/phcventures.ca\/#\/schema\/person\/c44279ba053e0deec14c02c4f1bdba97\",\"name\":\"Israel Resendiz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g\",\"caption\":\"Israel Resendiz\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AI Virtual Biomarker Staining Speeds Cancer Research","description":"Providence Health Care Ventures and ViewsML partner to use AI-driven virtual biomarker staining, accelerating cancer research.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/phcventures.ca\/fr\/ai-virtual-biomarker-cancer-research\/","og_locale":"fr_CA","og_type":"article","og_title":"AI Virtual Staining Partnership Accelerates Cancer Research","og_description":"Providence Health Care Ventures and ViewsML are using AI-driven virtual biomarker staining to speed cancer research and digital pathology\u2014cutting analysis from weeks to days.","og_url":"https:\/\/phcventures.ca\/fr\/ai-virtual-biomarker-cancer-research\/","og_site_name":"Providence Health Care Ventures","article_published_time":"2025-09-25T23:44:58+00:00","article_modified_time":"2025-10-17T22:16:18+00:00","og_image":[{"width":800,"height":500,"url":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg","type":"image\/jpeg"}],"author":"Israel Resendiz","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Israel Resendiz","Estimation du temps de lecture":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#article","isPartOf":{"@id":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/"},"author":{"name":"Israel Resendiz","@id":"https:\/\/phcventures.ca\/#\/schema\/person\/c44279ba053e0deec14c02c4f1bdba97"},"headline":"Vancouver Partnership Uses AI-Driven Virtual Biomarker Staining to Accelerate Cancer Research and Digital Pathology","datePublished":"2025-09-25T23:44:58+00:00","dateModified":"2025-10-17T22:16:18+00:00","mainEntityOfPage":{"@id":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/"},"wordCount":767,"publisher":{"@id":"https:\/\/phcventures.ca\/#organization"},"image":{"@id":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#primaryimage"},"thumbnailUrl":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg","articleSection":["Uncategorized"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/","url":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/","name":"AI Virtual Biomarker Staining Speeds Cancer Research","isPartOf":{"@id":"https:\/\/phcventures.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#primaryimage"},"image":{"@id":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#primaryimage"},"thumbnailUrl":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg","datePublished":"2025-09-25T23:44:58+00:00","dateModified":"2025-10-17T22:16:18+00:00","description":"Providence Health Care Ventures and ViewsML partner to use AI-driven virtual biomarker staining, accelerating cancer research.","breadcrumb":{"@id":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#primaryimage","url":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg","contentUrl":"https:\/\/phcventures.ca\/wp-content\/uploads\/2025\/09\/ai-virtual-biomarker-cancer-research.jpg","width":800,"height":500,"caption":"AI Virtual Biomarker Staining Speeds Cancer Research"},{"@type":"BreadcrumbList","@id":"https:\/\/phcventures.ca\/ai-virtual-biomarker-cancer-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/phcventures.ca\/"},{"@type":"ListItem","position":2,"name":"Vancouver Partnership Uses AI-Driven Virtual Biomarker Staining to Accelerate Cancer Research and Digital Pathology"}]},{"@type":"WebSite","@id":"https:\/\/phcventures.ca\/#website","url":"https:\/\/phcventures.ca\/","name":"Providence Health Care Ventures","description":"","publisher":{"@id":"https:\/\/phcventures.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/phcventures.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/phcventures.ca\/#organization","name":"Providence Health Care Ventures","url":"https:\/\/phcventures.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/phcventures.ca\/#\/schema\/logo\/image\/","url":"https:\/\/phcventures.ca\/wp-content\/uploads\/2024\/01\/PHC-Ventures-NoTagline-RGB-1.svg","contentUrl":"https:\/\/phcventures.ca\/wp-content\/uploads\/2024\/01\/PHC-Ventures-NoTagline-RGB-1.svg","width":"1024","height":"1024","caption":"Providence Health Care Ventures"},"image":{"@id":"https:\/\/phcventures.ca\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/phcventures.ca\/#\/schema\/person\/c44279ba053e0deec14c02c4f1bdba97","name":"Isra\u00ebl Resendiz","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c9ce47707fa8f08396b31e5b99c771898bd235916d407beda4cab8fcdcb1090?s=96&d=mm&r=g","caption":"Israel Resendiz"}}]}},"_links":{"self":[{"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/posts\/2051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/comments?post=2051"}],"version-history":[{"count":5,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/posts\/2051\/revisions"}],"predecessor-version":[{"id":2072,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/posts\/2051\/revisions\/2072"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/media\/2052"}],"wp:attachment":[{"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/media?parent=2051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/categories?post=2051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/phcventures.ca\/fr\/wp-json\/wp\/v2\/tags?post=2051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}